Parabilis Medicines, Inc Common Stock
Yahoo Finance • 23 days ago
Phanes Therapeutics to participate in Longwood Healthcare Leaders Boston CEO, November 2-3, 2026
SAN DIEGO, Oct. 13, 2026 /PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical-stage biotech company focused on innovative drug discovery and development in immuno-oncology (IO), announced that Ming Wang (CEO) will participate in... Full story
Yahoo Finance • 2 months ago
Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors
Parabilis Medicines, Inc. CAMBRIDGE, Mass., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines (Nasdaq: PBLS), a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases... Full story
- JNJ
Mentioned:
Yahoo Finance • 4 months ago
Here Are Monday’s Best Wall Street Analyst Research Calls: Agnico Eagle Mines, Datadog, Delta Air Lines, Gilead Sciences, Okta, Pfizer, Regions Financial, T-Mobile, and More
Quick Read T-Mobile (TMUS) and Gilead Sciences (GILD) both earned Buy upgrades Monday, with Bank of America and HSBC setting targets of $220 and $155 respectively. Pfizer (PFE) and Datadog (DDOG) both took ratings cuts Monday, though Bern... Full story